Pacific Smiles Group Valuation
Is PSQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of PSQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: PSQ (A$1.4) wird unter unserer Schätzung des Fair Value (A$2.19) gehandelt.
Deutlich unter dem Marktwert: PSQ wird um mehr als 20 % unter dem Marktwert gehandelt.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PSQ?
Other financial metrics that can be useful for relative valuation.
| What is PSQ's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | AU$257.72m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.9x |
| Enterprise Value/EBITDA | 10.9x |
| PEG Ratio | 1.9x |
Price to Earnings Ratio vs Peers
How does PSQ's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 35.3x | ||
MVF Monash IVF Group | 23.5x | 14.8% | AU$557.2m |
CAJ Capitol Health | 42.5x | 38.7% | AU$261.0m |
RHC Ramsay Health Care | 55.1x | 18.3% | AU$12.5b |
PGC Paragon Care | 20.1x | 20.7% | AU$213.7m |
PSQ Pacific Smiles Group | 38.5x | 19.9% | AU$257.7m |
Price-To-Earnings gegen Gleichaltrige: PSQ ist auf der Grundlage des Price-To-Earnings Verhältnisses (36x) im Vergleich zum Durchschnitt der Vergleichsgruppe (34.9x) teuer.
Price to Earnings Ratio vs Industry
How does PSQ's PE Ratio compare vs other companies in the Global Healthcare Industry?
Price-To-Earnings gegen Industrie: PSQ ist teuer, wenn man sein Price-To-Earnings Verhältnis (92.3x) mit dem Global Healthcare Branchendurchschnitt (23x) vergleicht.
Price to Earnings Ratio vs Fair Ratio
What is PSQ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 38.5x |
| Fair PE Ratio | 37.4x |
PM vs. Fair Ratio: PSQ ist teuer auf der Grundlage des Verhältnisses Price-To-Earnings (92.3x) im Vergleich zum geschätzten fairen Verhältnis Price-To-Earnings (33.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | AU$1.60 | AU$1.51 -5.5% | 15.2% | AU$1.90 | AU$1.33 | n/a | 4 |
| Mar ’25 | AU$1.43 | AU$1.57 +9.9% | 15.0% | AU$1.90 | AU$1.40 | n/a | 3 |
| Feb ’25 | AU$1.45 | AU$1.36 -6.2% | 27.7% | AU$1.80 | AU$0.88 | n/a | 3 |
| Jan ’25 | AU$1.46 | AU$1.24 -14.8% | 32.1% | AU$1.80 | AU$0.88 | n/a | 3 |
| Dec ’24 | AU$1.03 | AU$1.30 +26.5% | 27.6% | AU$1.80 | AU$0.88 | n/a | 4 |
| Nov ’24 | AU$1.18 | AU$1.68 +42.6% | 14.8% | AU$2.10 | AU$1.48 | n/a | 4 |
| Oct ’24 | AU$1.41 | AU$1.68 +19.8% | 14.8% | AU$2.10 | AU$1.48 | n/a | 4 |
| Sep ’24 | AU$1.48 | AU$1.68 +14.1% | 14.8% | AU$2.10 | AU$1.48 | n/a | 4 |
| Aug ’24 | AU$1.47 | AU$1.63 +11.0% | 13.1% | AU$2.00 | AU$1.48 | n/a | 4 |
| Jul ’24 | AU$1.36 | AU$1.56 +14.9% | 17.6% | AU$2.00 | AU$1.25 | n/a | 4 |
| Jun ’24 | AU$1.35 | AU$1.56 +15.4% | 17.6% | AU$2.00 | AU$1.25 | n/a | 4 |
| May ’24 | AU$1.38 | AU$1.58 +14.7% | 19.7% | AU$2.00 | AU$1.25 | n/a | 3 |
| Apr ’24 | AU$1.17 | AU$1.57 +33.5% | 17.4% | AU$2.00 | AU$1.25 | AU$1.60 | 4 |
| Mar ’24 | AU$1.16 | AU$1.57 +34.9% | 17.4% | AU$2.00 | AU$1.25 | AU$1.43 | 4 |
| Feb ’24 | AU$1.45 | AU$1.83 +26.0% | 16.3% | AU$2.30 | AU$1.51 | AU$1.45 | 4 |
| Jan ’24 | AU$1.53 | AU$1.85 +21.0% | 14.9% | AU$2.30 | AU$1.51 | AU$1.46 | 5 |
| Dec ’23 | AU$1.60 | AU$1.85 +15.7% | 14.9% | AU$2.30 | AU$1.51 | AU$1.03 | 5 |
| Nov ’23 | AU$1.46 | AU$1.90 +29.9% | 16.1% | AU$2.30 | AU$1.51 | AU$1.18 | 5 |
| Oct ’23 | AU$1.49 | AU$1.90 +27.2% | 16.1% | AU$2.30 | AU$1.51 | AU$1.41 | 5 |
| Sep ’23 | AU$1.45 | AU$1.99 +37.4% | 13.2% | AU$2.30 | AU$1.67 | AU$1.48 | 4 |
| Aug ’23 | AU$1.75 | AU$2.15 +22.9% | 6.8% | AU$2.30 | AU$1.95 | AU$1.47 | 3 |
| Jul ’23 | AU$1.79 | AU$2.44 +36.6% | 5.4% | AU$2.62 | AU$2.30 | AU$1.36 | 3 |
| Jun ’23 | AU$1.57 | AU$2.67 +70.2% | 9.3% | AU$3.00 | AU$2.40 | AU$1.35 | 3 |
| May ’23 | AU$2.32 | AU$2.90 +25.0% | 7.0% | AU$3.08 | AU$2.62 | AU$1.38 | 3 |
| Apr ’23 | AU$2.19 | AU$2.98 +36.2% | 3.7% | AU$3.08 | AU$2.80 | AU$1.17 | 4 |
Analysten-Prognose: Das Kursziel ist niedriger als der aktuelle Aktienkurs.